


















In a new article published in the journal Aging, Borras 
et al. report that Ras-GRF1 homozigous deletion 
increases both median and maximum longevity in 
laboratory mice [1]. The human Ras, superfamily now 
counts more than 150 different proteins subdivided into 
five different protein families: Ras, Rho, Rab, Arf and 
Ran. These protein families regulate many cellular 
processes [2] including cellular differentiation and 
proliferation (Ras), cell citoskeleton organization and 
cell shape (Rho), intracellular protein trafficking (Rab, 
Arf) and nucleo-citoplasmic transport (Ran). 
 
Ras protein, the founding member of the small GTP 
binding protein superfamily, is found mutated in 30% of 
all human tumors and, in mammals, consists of three 
genes and four gene products (N-Ras, H-Ras, K-Ras4A 
and KRas4B). Many of these proteins are ubiquitously 
expressed but regulated by a multitude of specific 
Guanine nucleotide Exchange Factors (GEFs) and 
GTPase Activating Proteins (GAPs). In fact, even 
though this protein superfamily has the endogenous 
capability to hydrolyze the bound GTP, GEFs and 
GAPs, respectively catalyze the activating and the 
inactivating reactions [3]. It is interesting to note that, 
although Ras-GRF1 (one of the mammalian GEFs) 
shows only partial homology to the yeast CDC25 (one 
of the two yeast GEFs) and mammalian and yeast Ras 
proteins have limited functional homology, both 
exchange factors are regulated by the PKA 
serine/threonine kinase [4, 5] suggesting the existence 
of conserved Ras-dependent signaling networks.  Both 
RasGRFs were first discovered for their ability to 
exchange the nucleotide bound to Ras proteins [6, 7] but 





















Other than the REM and CDC25 domain, capable of 
exchanging the Ras-bound GDP, full length RasGRFs 
contain, in fact, a PH domain that can interact with the 
NGF receptor TrkA  [31] and an IQ domain capable of 
calmodulin binding and responsible for calcium 
modulation [8; 9]. It also contains a second PH-DH 
domain that is capable of binding to membrane bound 
PI(4,5)P2, microtubules [10], phosphatidic acid, Rho 
and Rac GTPase [11, 12, 5] and spinophilin, a scaffold 
protein that interact with actin filaments and p70 S6 
kinase [13].  It is therefore possible that the RasGRF1 -
/- mouse phenotype may be due to the impairment of 
GTP binding proteins other than Ras or to inhibition of 
other signaling cascades. However, it must be noted that 
Ras-GRF1 signaling is required for normal beta cell 
development and glucose homeostasis and that isolated 
islet from GRF1 knockout fail to activate Akt and Erk 
[14] suggesting a major role of RasGRF1 in Ras 
activation in this cell type. A clear but much reduced 
effect of the same knockout can be also seen in the 
amount of activated Erk protein in isolated retina [15]. 
 
Ras-GRF1 was previously implicated in beta cell 
langherans islet development, glucose homeostasis [14], 
learning and memory impairment and retinal defects 
[16, 17, 18]. More recently [19] Ras-GRF1 has been 
invoked as a possible explanation for the longevity 
observed in mice obtained without paternal contribution 
[20].  These mice generated using two sets of female 
genomes display increased average longevity and 
reduced body weight. Since the RasGRF1 locus is 
imprinted in female gametogenesis, leaving the whole 
protein production to the paternal allele, it was argued 
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Ras-GRF1 is normally expressed in brain 
(hypothalamus and hippocampus), pancreatic cells and 
skeletal muscle [21]. Messenger length and composition 
are quite heterogeneous because the Ras-GRF1 locus is 
heavily affected by alternative splicing. This results in a 
variety of mRNA isoforms that show tissue and 
developmental specific expression. Consequently, 
protein isoforms range from a 140 KDa full-length 
protein expressed in brain and in pancreatic islet to the 
smallest 20kDa isoform Ras-GRFβ, expressed in mouse 
pancreas [21]. These isoforms share only some of the 
functional domains raising the possibility that different 
isoforms may perform different tasks.  
 
In their study, Borras et al.  [1] find increased average 
and maximal Lifespan in RasGrf1-/- mice. Survival 
curves revealed a marked increase (20%) in the average 
lifespan of RasGrf1-/- male mice (mean values WT: 
100.5±4.2 weeks and RasGrf1-/-: 120.7±4.7 weeks; 
median WT: 104 weeks; RasGrf1-/-: 124 weeks) and 
mice with RasGrf1-/- showed better motor coordination 
than controls. At the molecular level they find:  a) 
Increased Expression of the 16S rRNA in RasGrf1-/- 
mice. 16S rRNA is one of the mitochondrial rRNA and 
mitochondrial gene expression and function has been 
demonstrated to positively correlate with longevity in 
organisms from yeast to human [40, 41, 42, 43] b) 
Increased expression of SIRT1 in RasGrf1-/- mice. 
Sirtuins play a role in a variety of diseases [44], but 
their importance in mammalian lifespan is not clear 
[45]. c) Maintained in vivo glucose uptake in aged 
RasGrf1-/- mice. 
 
Reduced glucose uptake is associated with aging [39]. 
They analyzed the in vivo glucose uptake in young and 
old animals showing higher uptake levels in RasGRF1-
/- mice with respect to the wild type of the same age, d) 
RasGRF1-/- mice displayed reduced IGF1 activity and 
blood metabolomic analysis showed clear similarities 
with calorie-restricted animals. IGF1 activity has a 
consistent effect on the aging process [23], suggesting 
that the downstream Ras pathway may play a central 
role in this process in mammals as it does in yeast [23]. 
Higher glycogen content in mice depleted of the 
RasGRF1 was also observed. Notably, glycogen and 
trehalose content positively correlates with stress 
resistance and Ras/AC/PKA depletion in yeast while 
constitutively activated Ras/AC/PKA pathway reduces 
both carbohydrate content [22]. Borras et al. suggest the 
longevity phenotype observed in mice with 
homozygous Ras-GRF1 deletion may be the outcome of 
decreased Ras activity. 
In yeast the Ras, Tor and Sch9 signaling pathways are 
partly responsible for integrating nutrient inputs into 
cell growth, division and aging [23]. Impairment of the 
Ras/AC/PKA pathway increases stress resistance and 
longevity [24, 25, 26] through different downstream 
effectors whose roles are functionally conserved in 
higher eukaryotes including mammals [23]. 
Mechanistically, downregulation of Ras/AC/PKA in 
yeast provokes relocalization/activation of the 
transcription factors Msn2/4 [28], activation of the 
transcription factors Gis1 through Rim15, [29, 26, 28, 
30] and Hsf1 activation [29].  All these factors enhance 
cellular protection systems activating stress response 
genes such as SODs, catalase, HSPs, autophagy and 
probably many others. [31, 23, 27, 28].  
 
Orthologs of genes that function downstream of Ras in 
yeast have also been implicated in longevity extension 
in mice. Deletion of the mouse adenylate cyclase type 5 
and the consequently PKA downregulation extends 
lifespan, stress resistance and mediates upregulation of 
SODs [32] and mice lacking PKA RII or Cβ subunits 
are protected from age-related deleterious changes such 
as weight gain, hypertrophic liver and cardiac 
dysfunction and enlargement [33, 34]. In addition, 
serum from a cohort of individuals with Growth 
Hormone Receptor (GHR) mutations, showing very low 
cancer and diabetes incidence, inhibited the expression 
of N-Ras, TOR and PKA when added to cultured 
primary human epithelial cells [35]. 
 
It is therefore tempting to propose that the pro-longevity 
effect of the homozygous Ras-GRF1 deletion observed 
by Borras is due to a reduced activity of the Ras or an 
analogous pathway and to consider that the increased 
longevity observed may be evidence for the conserved 
role of the Ras pathway in the aging process in organisms 
ranging from yeast to mammals [49]. However, the 
presence of more isoforms of the Ras-GRF1 coupled 
with the loose ligand specificity of Ras-GRF1 that is 
capable to bind Ras, Rac, Rho GTPase, microtubules, 
PI(4,5)P2 and fosfatidic acid indicates that additional 
studies are necessary to determine how altered Ras-GRF1 
signaling promotes aging in mammals.  
 
In summary, the identification of a pro-aging role of Ras 
in aging therapy is an important and welcomed discovery 
especially considering that drug companies have 
identified a number of compounds capable to inhibit 
GEFs such as Brefeldin A (large ArfGef), SecinH3 
(small ArfGef) and NSC23766 (RacGef) [36, 37, 38]. 
These examples demonstrate that pharmacological GEF 
inhibition may be a feasible strategy to extend longevity. 
In  particular,  the  possibility  to  obtain  GEF  inhibition, 
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GEF, an approach described as “interfacial inhibition” 
[36], is very interesting because the compound doesn’t 
need to compete with the natural substrate and hence 
inhibition may be obtained even by low affinity 
compounds. Other interfacial inhibitors are already in 
clinical practice. Rapamycin for example, which 
inhibits mTOR signaling, has been shown to extend the 
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